Portland Investment Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Portland Investment Counsel's LLY Position: Q1 2026 in Review
Portland Investment Counsel increased its Eli Lilly (LLY) stake by 25% in Q1 2026, buying an estimated $295K and bringing the position to 1,458 shares worth $1.34M. The position accounts for 0.43% of the portfolio, ranked #29.
Portland Investment Counsel first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Portland Investment Counsel held 1,458 shares of Eli Lilly worth $1.34M as of Q1 2026.
- Portland Investment Counsel bought 291 Eli Lilly shares in Q1 2026, an estimated $295K.
- Eli Lilly made up 0.43% of Portland Investment Counsel's portfolio in Q1 2026, its #29 holding.
- Portland Investment Counsel first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Portland Investment Counsel's 13F filing for Q1 2026, filed 14 May 2026.